From: Clinical performance of additively manufactured subperiosteal implants: a systematic review
Authors | Mean surgery time (min) | Follow-up (months) | Implant survival | Implant fitting | Complications |
---|---|---|---|---|---|
Mangano et al. [40] | 44.3 ± SD 19.4 | 12 | 100% | Mean rating: 7 out of 10 SD ± 1.6, median 7, 95% CI 6–8 Satisfactory 8/10 Insufficient 2/10* *adapted during surgery and placed | 1/10 patient immediate postoperative complications (pain, discomfort, swelling) 2/10 patient late complications (provisional restoration fracture) |
Van den Borre et al. [36] | N.A | 12 | 100% | N.A | No complications reported |
Van den Borre et al. [39] | N.A | 30.1 *917 days; SD ± 306.89 days | 100% | N.A | 12/40 postoperative inflammation (i.e., swelling, marked redness, pain) 6/40 apparent soft tissue infection, drainage, exploration and/or mechanical debridement needed 3/40 required one connecting post removal due to persistent and uncontrollable infection 26/40 Partial exposure of the arms not experienced as a functional or esthetic impediment by patients 1/40 Mobility of the implant (> 1 mm) |
Chamorro Pons et al. [41] | 80 | mean: 18.4 range: 4 to 36 | 100% | Satisfactory 8/8 | 1/8 needed prosthetic removal and recontouring (soft tissue inflammation/ulceration) |
Cebrián et al. [29] | N.A | mean: 20 range: 9 to 38 | 100% | N.A | No complications reported |
Nemtoi et al. [42] | 86 | 12 | 93% | 5/16 not fully satisfactory Mean satisfaction rate: 4/5 | 3/16 bleeding 6/16 implant exposure 1/16 implant failure 1/16 fracture of temporary prosthesis |
Cerea et al. [43] | N.A | 24 | 95.8% | N.A | 3/70 failure due to infection 4/70 postoperative pain/discomfort/swelling 1/70 recurrent infections 4/70 fracture of provisional prosthesis 2/70 ceramic chipping in the definitive prosthesis |
Dimitroulis et al. [44] | N.A | Mean: 22.1 range: 5 to 57 | 95% (85.7% success rate) | Satisfactory 21/21 | 1/21 Failure (explanted because of chronic pain) 4/21 Salvaged (replacing exposed frames or adding more bone screws) 2/21 (considered failures because exposure of the framework even though the device is still functional) |
Mounir et al. [45] | N.A | 12 | 100% | N.A | 1/5 wound dehiscence and exposure of the implant. Fully covered subsequently after removal of uncovered rim of the implant 5/5 Ti implants showed 1–2 mm exposure of the platform around the posts. (No interference with prosthetic loading or patient dissatisfaction was reported) |
Gellrich et al. [46] | N.A | Mean: 18 range: 14 to 21 | 100% | Satisfactory 3/3 | No complications reported except for partial discomfort/pain in one patient |
Korn et al. [47] | 135 | Mean: 8.2 range: 1 to 29 | 100% | N.A | Infection 1/10 patients Exposure of the framework 2/10 patients Screw-loss 1/10 patients |
Rahlf et al. [48] | 146 | Mean:18.2 range: 6 to 40 | 100% | N.A | 6/6 chronic mucositis 3/6 Framework exposure around posts |
Korn et al. [49] | 127 | Mean: 26 Range: 6 to 74 | 100% | N.A | 1/20 severe infection 1/20 exposed screws needed remotion 9/20 Exposure of the framework |